Ampligen (rintatolimod) Investigational RNA immunomodulator being studied for pancreatic cancer and other conditions; its therapeutic uses remain unapproved by the FDA.
Visit productCosigns Received
Be the first Cosign
Put your name behind Ampligen (rintatolimod).
Add it to your Products I use list and share why you use it.